Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 969 | 476 | 5,244 | 1,173 | 0 |
| Gross Profit | 969 | 476 | 5,244 | 1,173 | N/A |
| Operating Expenses | 12,745 | 8,159 | -15,222 | 9,427 | 18,083 |
| Operating Income | -11,776 | -7,683 | 20,466 | -8,254 | -18,083 |
| Other Income | 636 | 594 | -937 | 470 | 812 |
| Pre-tax Income | -11,140 | -7,089 | 19,529 | -7,784 | -17,271 |
| Net Income Continuous | -11,140 | -7,089 | 19,529 | -7,784 | -17,271 |
| Net Income | $-11,140 | $-7,089 | $19,529 | $-7,784 | $-17,271 |
| EPS Basic Total Ops | -12.73 | -8.10 | -12.79 | -8.90 | -4.64 |
| EPS Basic Continuous Ops | -12.73 | -8.10 | -12.74 | -8.90 | -4.70 |
| EPS Diluted Total Ops | -12.73 | -8.10 | -12.79 | -8.90 | -4.64 |
| EPS Diluted Continuous Ops | -12.73 | -8.10 | -12.74 | -8.90 | -4.70 |
| EBITDA(a) | $-11,900 | $-7,960 | $20,113 | $-9,348 | $-17,606 |